⚠️
Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
High fills per patient
Risk indicators are statistical patterns, not allegations. Learn more
15,744
Total Claims
$998K
Drug Cost
736
Beneficiaries
$1,356
Cost/Patient
Risk Score Breakdown 3/100
Low (0)Moderate (15)Elevated (30)High (50+)
High fills per patient+3
Score components are additive. Read full methodology
Peer Comparison vs. 18,720 Cardiology providers
-11%
Cost per patient vs peers
$1,356 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 13,768 claims · $181K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 299 | $187K |
| Evolocumab | 223 | $134K |
| Dapagliflozin Propanediol | 120 | $87K |
| Empagliflozin | 94 | $72K |
| Rivaroxaban | 96 | $63K |
| Sacubitril/Valsartan | 35 | $30K |
| Levothyroxine Sodium | 510 | $30K |
| Sitagliptin Phos/Metformin Hcl | 38 | $24K |
| Sitagliptin Phosphate | 41 | $24K |
| Ticagrelor | 46 | $22K |
| Dronedarone Hcl | 23 | $18K |
| Evolocumab | 25 | $18K |
| Candesartan Cilexetil | 175 | $14K |
| Valsartan | 452 | $13K |
| Valsartan | 22 | $13K |
Prescribing Profile
Patient Profile
75
Avg Age
60%
Female
2.26
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About